[SUGGESTION] https://doi.org/10.1038/s41591-022-01882-4 (Harari et al) Number of case series': N = 6 patients, N = 34 sequences

[thomasppeacock]

A case series will only be included if it fits the inclusion criteria specified in the original paper. As well as the inclusion criteria specified within the paper only public sequences with available accessions will be included in this repository via this route.

Please confirm that each of the below criteria is met by the case series('s) suggested for inclusion:

• [x ] Are at least two SARS-CoV-2 genomes from this case series publicly available?
• [ x] Is there a time period of at least 28 days between the first genome in the series and the last?
• [ x] Is there sufficient public clinical evidence that the patient possessed a suppressed immune system during the time period covered by these genomes?
• [ x] Is there sufficient evidence that these genomes are obtained by sampling the same patient?
• [ x] Is the first genome within the case series sufficiently high (>= 95% coverage overall, 100% in spike gene) quality? Later genomes can be of lower quality but the "day 0" genome is treated as a baseline.

Information on case series

Accession	Day / Date	Coverage %	DOI
Patient 1
EPI_ISL_8996171	2021-01-17	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_9010725	2021-02-08	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996172	2021-02-09	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_9010726	2021-02-28	n/a	https://doi.org/10.1038/s41591-022-01882-4
Patient 2
EPI_ISL_8996199	2020-08-12	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996200	2020-09-29	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996201	2020-09-29	n/a	https://doi.org/10.1038/s41591-022-01882-4
Patient 3
EPI_ISL_8996173	2021-02-01	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996174	2021-02-10	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996175	2021-02-17	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996176	2021-03-16	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996177	2021-03-25	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996178	2021-04-22	n/a	https://doi.org/10.1038/s41591-022-01882-4
Patient 4
EPI_ISL_8996179	2021-01-27	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996180	2021-02-06	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_9010727	2021-02-09	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996181	2021-02-14	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996182	2021-02-21	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996183	2021-02-24	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996184	2021-03-03	n/a	https://doi.org/10.1038/s41591-022-01882-4
Patient 5
EPI_ISL_8996185	2020-10-06	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996186	2020-10-18	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996187	2020-10-26	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996188	2020-11-02	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996189	2020-11-05	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996190	2020-11-15	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996191	2020-11-19	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996192	2020-12-13	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996193	2020-12-20	n/a	https://doi.org/10.1038/s41591-022-01882-4
Patient 6
EPI_ISL_8996194	2020-12-16	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996195	2021-01-07	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996196	2021-01-15	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996197	2021-01-20	n/a	https://doi.org/10.1038/s41591-022-01882-4
EPI_ISL_8996198	2021-01-22	n/a	https://doi.org/10.1038/s41591-022-01882-4